Eustratios Bananis
- Rheumatology top 1%
- Oncology top 5%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Hematology top 2%
- Co-authors
- Allan W. WolkoffJohn W. MurrayRoy FleischmannRichard J. StockertJoanne FuimanMajed KhraishiPhilip J. MeaseDaniel Alvarez
- Topics
- Rheumatoid Arthritis Research and Therapies (27 papers)Advanced Breast Cancer Therapies (21 papers)Chronic Lymphocytic Leukemia Research (16 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Eustratios Bananis
58 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Rheumatology 935
- Oncology 635
- Immunology 597
- Pulmonary and Respiratory Medicine 581
- Hematology 477
Countries citing papers authored by Eustratios Bananis
This map shows the geographic impact of Eustratios Bananis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eustratios Bananis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eustratios Bananis more than expected).
Fields of papers citing papers by Eustratios Bananis
This network shows the impact of papers produced by Eustratios Bananis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eustratios Bananis. The network helps show where Eustratios Bananis may publish in the future.
Co-authorship network of co-authors of Eustratios Bananis
This figure shows the co-authorship network connecting the top 25 collaborators of Eustratios Bananis. A scholar is included among the top collaborators of Eustratios Bananis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eustratios Bananis. Eustratios Bananis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Studybreakdown → | 114 |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 40 | |
| 7 | 21 | |
| 8 | 111 | |
| 9 | 24 | |
| 10 | 33 | |
| 11 | 9 | |
| 12 | 35 | |
| 13 | 59 | |
| 14 | 13 | |
| 15 | Impact of etanercept-methotrexate therapy on patient-reported outcomes in moderately active rheumatoid arthritis: Australian results from the induction period of preserve trial | 1 |
| 16 | 62 | |
| 17 | 2 | |
| 18 | 30 | |
| 19 | 55 | |
| 20 | 22 |
About Eustratios Bananis
Eustratios Bananis is a scholar working on Rheumatology, Genetics and Hematology, having authored 60 papers that have together received 2.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (27 papers), Advanced Breast Cancer Therapies (21 papers) and Chronic Lymphocytic Leukemia Research (16 papers). The work is most often cited by research in Rheumatology (935 citations), Hematology (477 citations) and Immunology (597 citations). Eustratios Bananis has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Allan W. Wolkoff, John W. Murray, Roy Fleischmann, Richard J. Stockert, Joanne Fuiman, Majed Khraishi, Philip J. Mease, Daniel Alvarez, Dafna D. Gladman and Peter Satir. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.